Prozac proves no better than a placebo in treating kids with autism

Drugs called SSRIs didn’t ease obsessive-compulsive symptoms in children with the disorder

Prozac pills

A randomized clinical trial found that the antidepressant marketed as Prozac is no more effective than a placebo at treating obsessive-compulsive symptoms in kids and teens with autism.

BSIP SA/Alamy Stock Photo

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Health & Medicine

From the Nature Index

Paid Content